Aims To obtain information about the speciality of clinical pharmacology and therapeutics in the United Kingdom. Methods A survey of the views of 26 individuals in academic posts in clinical pharmacology and therapeutics was carried out by postal questionnaire. Response rate was 100%. Results Of 25 assessable responses of 25 centres, there were 35 academic staff of professorial status (median 2, range 0-5) and 61 staff of reader/senior lecturer status (median 2, range 0-5) but only 20 clinical staff in training grades in 19 institutions. All had extensive clinical commitments. Two-thirds of respondents considered that the speciality was stable locally and nationally. However, recruitment of trainees was poor with only 8% of responders having several good applicants for each post and 90% reported that recruitment had deteriorated in the last 5-10 years. Likely good future careers for clinical pharmacologists in training were considered by 75-80% of respondents to likely lie in the pharmaceutical industry or regulatory authorities. Greater flexibility is required to facilitate training in clinical pharmacology and therapeutics. Conclusions Clincal pharmacology and therapeutics in the United Kingdom has a strong academic base but a sub-optimal age structure. Recent experience in recruitment into training posts was disappointing. This may reflect wider problems of recruitment into academic medicine in this country.
Introduction in district hospitals was envisaged to complement the career openings in undergraduate teaching and research in medical Clinical Pharmacology and Therapeutics emerged as a discipline in the late 1950s/early 1960s from a variety of schools. In practice, very few non-teaching hospital appointments were made of specialists in clinical pharmacology. A origins. In some countries it originated in departments of basic pharmacology or pharmacy. In the United Kingdom further factor has been the move to super-specialisation in medicine and the increasing technical and procedure-driven it developed in many cases as a research discipline in association with Clinical Medicine for the application of aspects of medical specialties which has eclipsed not only the clinical pharmacologist but the traditional general physician. new discoveries in pharmacology in the investigation of human disease and its treatment. Strong research groups Even the powerful academic bases of clinical pharmacology in medical schools have been eroded by departmental mergers, exploiting new research methods emerged at several centres including the Royal Postgraduate Medical School, lateral career moves, retirals and deaths. In 1997 specialist medical training in the United Kingdom Hammersmith Hospital, London. The Specialty also thrived in older established Medical Schools with a strong tradition undergoes major revision to bring it into line with training in other European Union countries. From January 1997 in 'Materia Medica' and 'Applied Therapeutics'. Although the catalyst to the development of clinical pharmacology in training in Clinical Pharmacology and Therapeutics, like other medical specialties, will be limited to individuals with many cases was clinical research, the main resource which enabled the subject to expand through the 1960s and '70s an allocated national training number in an approved training programme. After completing the necessary period as a was its academic base and established role in teaching clinical aspects of pharmacology and therapeutics to undergraduate specialist registrar, the procedure is that application is made to the relevant Royal College who advise the Specialist medical students. In the early days industrial and commercial applications did not figure large and involvement in Training Authority that it would be appropriate to award a certificate of completion of specialist training which entitles government, agencies or regulatory authorities were minor, peripheral and 'part-time' interests. the holder to appear on the specialist register held by the General Medical Council. From January 1997 only individuals The discipline of clinical pharmacology developed and grew in the 1970s and '80s. Professional training programmes with such specialist registration would be eligible to apply for consultant appointments in the NHS and elsewhere in Europe. were developed and clinical specialists were trained with expertise in clinical pharmacology and internal medicine. In
In view of these major developments, most particularly the introduction of a new training grade, it is pertinent to review the state of clinical pharmacology in the U.K. at this time at the activities of the relevant professional society. In the medical outpatient services and specialist clinics. Twentythree out of 24 respondents had regular responsibility for early 1970s the nascent discipline in Britain chose not to form a separate society but to establish under the auspices of general medical in-patient beds (mean 24 beds, median 20, range 10-42). Clinical pharmacologists were on call for the British Pharmacology Society a 'Clinical Pharmacology section'. This section remains part of the British Pharmacology medical emergencies 5-6 days per month (range 2-10) and were responsible for 2 (range 1-4) general medical clinics Society and has always met jointly with the main 'basic' pharmacology society. However, the Clinical Pharmacology each week. Many special services were co-ordinated by clinical pharmacologists alone or in collaboration with other Section established its own journal, the British Journal of Clinical Pharmacology. This journal has grown to become specialists. These included hypertension clinics, epilepsy clinics, diabetic clinics, lipid clinics, stroke services and one of the most respected international publications in clinical pharmacology. In 1975 the Clinical Pharmacology Section of coronary care. The vast majority of clinical pharmacologists provide local support to Drug and Therapeutics Committees, the British Pharmacological Society met for Scientific Meetings on three occasions, where a total of 61 oral and Hospital or Regional Formulary Groups and organise Educational Case Conferences in Clinical Pharmacology. In poster communications were presented. As an indication of the rapid growth of the Clinical Section (in the discipline) in addition, two thirds contributed to Drug Information Services but only 2 out of 24 (less than 10%) were directly 1985 when the Section met on four occasions, there were 258 presentations. After a peak in the mid eighties the involved in Therapeutic Drug Monitoring. Academic respondents were invited to comment on future number of presentations at the Clinical Pharmacology Section meetings has fallen to a total of 121 presentations in 1995.
developments in Clinical Pharmacology and Therapeutics as a medical specialty in their own medical school and in the Another approach to obtaining information about a specialty is to canvass the academic leaders on their views U.K. as a whole ( respondents 46 new training posts were already identified (median 2 per unit, range 0-4) and 38 of these posts had Methods confirmed funding (median 2, range 0-3). A majority of training programmes had been approved by the local In all 26 individuals were identified and contacted by mail. All (100%) responded. In two cases the questionnaire was Postgraduate Dean. A less positive position emerged in response to questions not fully completed. In one case the medical school was undergoing a major reorganisation and a completed questionabout recent experience with recruitment (Table 2) . Only two (8%) had 'several good applicants for each post', while naire was promised within 3 months. The other medical school had no identified clinical pharmacologist on staff.
70% reported 'few good applicants', five (22%) felt they had had 'no good applicants' for recent training posts. Compared Neither of these institutions had present or projected training posts in clinical pharmacology.
with 5-10 years ago, 19 of 21 respondents felt that the recruitment position was worse and only two (10%) noted The questionnaire consisted of a series of questions relating to either the present state of clinical pharmacology in the no change. Three younger respondents who had only recently taken up senior academic positions, indicated that academic centre, future arrangements for the new grade and perceptions as to which areas were more or less important to they had no experience of recruitment in the past. Senior academics were asked to rank a range of academic the future of clinical pharmacology. The full questionnaire and a summary of responses is available on request.
and service activities in terms of their perceived importance to the future of clinical pharmacology. As all the respondents are employed in medical schools, it is perhaps not surprising Results and discussions that they all ranked undergraduate medical student teaching as 'very important'. Postgraduate educational roles were believed The picture that emerged varied from centre to centre. The academic base of clinical pharmacology appeared to be to be 'important' or 'very important' by 86-100%. National and local input into drug regulation and formularies was also strong. Of 25 assessable responses from 25 centres there were 35 academic staff of Professorial status (median 2, important or very important to all respondents. There was a much wider range of views on the importance of basic drug range 0-5) and 61 staff of Reader/Senior Lecturer status (median 2, range 0-4). There were however only 20 clinical discovery compared with clinical trials and provision of drug information. This probably reflects the diversity of clinical and staff of Lecturer/Academic training grade status in a total of 19 institutions. When asked to define the present clinical pharmacological interests and the influence of size and other local factors in different departments. responsibilities of clinical pharmacologists, all had extensive clinical service commitments usually in general internal
In response to a question 'where do you expect the future clinical pharmacologist will be employed after medicine providing emergency medical services, general in academia remain at least for the present. professional training grade. Clinical Pharmacology and Therapeutics in the U.K. still has a strong academic base but completion of training' there was agreement that academic a suboptimal age structure. Recent experience of recruitment departments and other teaching hospital posts were the most into training posts was widely viewed as disappointing. This likely location. While a District Hospital post was felt may, however, reflect wider problems of recruitment into unlikely by most respondents, there was support for the academic medicine and not be specialty specific. view that the Pharmaceutical Industry or a Regulatory
Most clinical pharmacologists make considerable contriAgency was a 'likely' or 'possible' career by 75-80% of butions to hospital medical services, especially in general respondents. The recognition of these alternative career medicine. Undergraduate medical education, and postgraduopportunities is encouraging in view of the recent introducate education are major activities, together with local and tion of clinical pharmacology training posts funded jointly national advice on drug therapy, formularies and regulatory by the Departments of Health and the Association of the issues. The development of posts jointly funded by industry British Pharmaceutical Industry [3] . and the Departments of Health is likely to extend training In addition to the formal questionnaire, respondents were opportunities but also a broader range of career opportunities. invited to add any specific comments they had about Clinical Pharmacology and Therapeutics remains a strong opportunities or threats to the future of Clinical academic discipline in the United Kingdom. However its Pharmacology and Therapeutics. Many expressed reserlong term survival will require full commitment of those vations on the attractiveness to potential trainees of a training who identify themselves as clinical pharmacologists and the in Clinical Pharmacology and General Medicine. There was emergence of attractive professional training programmes a widely expressed view that greater flexibility was required offering a range of career opportunities which appeal to to facilitate training in Clinical Pharmacology together with medical graduates in the late 1990s. another medical specialty. Triple accreditation (Clinical Pharmacology plus General Medicine plus another specialty) References was suggested but the training period was felt to be unrealistically long. the specialty.
